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ABSTRACT 
The chemiluminescence method for determination of TRAP (Total peroxyl 
Radical-trapping Antioxidant Parameter) based on that described by D.I. Thumham 
(1991) was established and evaluated. The assay has a wide analytical range (linear 
to 10,000 ^imol/L) with an average recovery of 101.1%. Within-day and between-
day precision are within tolerable limits. Within-day precision (C.V.) 2.5% and 
between-day precision〈 7% even at a low TRAP concentration o f 527 fimol/L. 
Consistent with a number of previous studies on the stability o f TRAP during 
storage, it is recommended that samples for TRAP assay preferentially be kept at • 
70°C and analysed within 2 weeks. Interference experiments showed that slightly 
hemolysed samples with hemoglobin concentration up to 0.7g/L do not affect 
TRAP appreciably while moderately to grossly hemolysed sanq)les are best avoided 
since a substantial drop in TRAP occurs. Lipemic samples with triglyceride 
concentrations of up to 11 mmol/L are not affected appreciably and thus can be 
analysed without prior ultracentrifligation. 
Serial determinations of TRAP in 22 healthy Chinese (dayl, 1 week, 2 
weeks, 4 weeks and 12 weeks) were carried out and the components o f Analytical, 
Intraindividual and Interindividual Variation determined: Analytical Variation 
( S D a ) = 29.6; Intraindividual Variation (SDj) 二 83.9 and Interindividual Variation 
(SDq) = 141. The following conclusions can be drawn from these data: i) the 
analytical goal for in^recision of the chemiluminescence method for measuring 
t r a p is fulfilled. (SD^< l /2 SDj) i i) The "Index of Individuality" for TRAP is 0.6, 
indicating that TRAP of the population has a high degree of individuality. Thus a 
population-based reference interval is insensitive for detecting change in an 
individual and conq)arison of TRAP values with those previously obtained in the 
same individual would be of greater value, iii) To be 95% confident that there is a 
significant difference between results obtained from an individual, there must be a 
change in TRAP of 249nmol/L. 
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Chapter I: Introduction 
The aim of this study was to establish the "TRAP" assay as described by 
Coll and Thumham (1) and to try to determine the intraindividual and 
interindividual variation o f TRAP in a group of healthy Chinese. TRAP stands for 
"Total (peroxyl) Radical-trapping Antioxidant Parameter". The assay mimics lipid 
peroxidation in vivo and enables one to measure the plasma's ability to inhibit 
peroxidation by scavenging peroxyl radicals in the reaction mixture. Lipid 
peroxidation is a deteriorating oxidative chain reaction that is initiated by free 
radicals (e.g. oxygen-derived radicals), and peroxyl radical scavenging is one o f the 
many antioxidant mechanisms that act to protect the body from radical damage. 
"TRAP" assessment is only a small element in the context of free radicals (oxygen 
derived radicals), related tissue damage (e.g. lipid peroxidation) and antioxidant 
defence. A general literature review of this background is given in Chapter 11. 
Following establishment of the method for TRAP, biological variation o f 
TRAP in a group of healthy Chinese over a period of 12 weeks was determined. 
Biological variation is made up of both intraindividual and interindividual 
components. Intraindividual variation is the fluctuation around the homeostatic 
setting point of an individual while interindividual variation is the variation between 
the setting points of individuals. Biological variation data are useful in several 
aspects (2): 
(i) for assessment of the desirable performance standard o f assays; 
(ii) for calculation of the "Index of Individuality" of an assay to 
determine whether it is more appropriate to compare a single result 
o f a patient to his own previous result or with an established 
population-based reference interval; 
(iii) to evaluate whether serial values obtained from an individual are 
significantly different. 
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Chanter 11 ； Background Knowledge 
2.1 Definition of Free Radical 
Electrons in atoms reside in space known as orbitals and each orbital can 
hold up to a maximum of 2 electrons. The arrangement o f electrons help in 
determining the stability of a compound. Stable compounds have electrons that are 
paired. Those with unpaired electrons appear to be more reactive and unstable (3). 
Any chemical species that possesses one or more unpaired electrons is called a free 
radical. This definition embraces the atom of Hydrogen (one unpaired electron), 
most transition metals and oxygen molecules. In order to stabilize itself, it might 
give or take one electron from a stable compound, in turn transforming the non-
radical into a new free radical. This proceeds as a chain reaction until the free 
radical's lone electron pairs up with another radical's unpaired electron (4). 
2.2 Oxygen Derived Radicals and Their Generation In Vivo 
The most important free radicals in aerobic cells are oxygen and its derived 
radicals. Figure 1 shows the various bondings in the diatomic oxygen molecule. The 
ground state diatomic oxygen molecule (O^) is itself a free radical with 2 unpaired 
electrons, each located in a antibonding orbital. These 2 unpaired electrons are 
of parallel spin. I f oxygen attempts to oxidize another molecule by accepting a pair 
of electrons, this pair of electrons must be of parallel spin to fit into the n* orbital 
of the O j molecule. This mechanism of orbital restriction together with the 
presence of antioxidant systems in our body help to prevent us from spontaneous 
combustion in the presence of air. During normal metabolism, ground state oxygen 
is normally reduced in four one-electron steps to water by the mitochondrial 
cytochrome oxidase pathway without releasing partially reduced intermediates (3)。 
02 + 4H^ + 4e- > lUp 
Thus it is the intermediate reduction products that are responsible for oxygen's 
toxicity and for oxidative stress. Ground state oxygen is excited to produce singlet 
oxygen when given extra energy. Singlet oxygen is a more reactive form of oxygen, 
existing in 2 states-^AgO^ and iSg+Oj. The hgO^ state could not be qualified as a 
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radical itself because it has no unpaired electron. ^Sg'^O^ state is a radical itself and 
is more reactive. The oxygen molecule wil l undergo univalent reduction to produce 
superoxide radical (O^'). This is considered less a radical than O^ itself because it 
only possesses 1 unpaired electron. Superoxide radical in a hydrophobic 
environment is a potent base, nucleophile and reducing agent (3,5). Both 
dismutation or divalent reduction of O〗in the presence of hydrogen ion wi l l result 
in production o f hydrogen peroxide (H^O^), and although this is not a free radical it 
can be problematic in 2 ways: firstly, it is water-soluble and can cross biological 
membranes (superoxide radical cannot except through an anion channel known to 
be present in erythrocyte membranes). Because of its limited reactivity, it can 
disperse easily. Secondly, H^O^ in the presence of ferrous ion (Fe】, or other 
transition metals wil l produce the highly reactive hydroxy radical (0H.)(5). 
Figure 1; Bonding in Diatomic Oxygen Molecule 
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Source: (3) Halliwell B. and Gutteridge J. Free Radicals in Biology and Medicine. 
2nd Edition. Oxford: Claredon Press, 12,1989. 
Superoxide radical, hydrogen peroxide and hydroxy radical are often 
referred to collectively as Reactive Oxygen Species (ROS). They appear to be more 
reactive with other molecules than O j (6). 
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2.2.1 Production of Singlet Oxygen 
Singlet oxygen is produced when several pigments such as flavin, porphyrin 
and chlorophyll are illuminated in the presence ofO^. These pigments absorb light 
and are excited to a higher energy state and in returning to the ground state the 
extra energy is transferred to molecular O ! producing singlet oxygen. Singlet 
oxygen is likely to be formed in pigment-containing illuminated systems such as the 
chloroplast of plant leaves, in some types of porphyria particularly in those with 
accumulation of protoporphyrin I X in the skin (5,7). 
2.2.2 Production of Superoxide Radical (0{) and Hydrogen Peroxide 
T Endogenous Production: 
Endogenously, these are constantly being produced as a by-product of 
normal aerobic metabolism or during, for example, phagocytosis. 
i) Mitochondrial Electron Transport: 
Leakage of "electrons" to molecular oxygen from the electron transport system 
occurs as a by-product in mitochondria and endoplasmic reticulum, resulting in the 
formation of superoxide radical and hydrogen peroxide (4). 
O2 + e- > O2-
O2 + 2e" + 2lt >H202 
/ 
i i) Enzymatic Activity at Different Subcellular Sites Catalysing the Production of 
Superoxide Radical and Hydrogen Peroxide: 
The rate of this enzymatic production of reactive oxygen species depends on the 
availability of cofactors, substrate concentration and oxygen tensions. Metabolic 
states such as hyperoxia, ischaemia or antibiotic therapy are known to promote free 
radical production (8). 
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a) Peroxisomes: 
Peroxisomes are a major source of cellular because of high 
concentration of oxidase. Example includes urate oxidase, D-amino acid 
oxidase, glycolate oxidase and L-hydroxyacid oxidase (3,9). 
urate oxidase 
urate + H2O + O^ > allantoin + 
D-amino acid oxidase 
D-RCHNH^COOH+H^O+O^ sRCOCOOH+H^O】擺 3 
ketoacid 
Peroxisomal catalase wil l normally help to metabolize most of the H】。！ 
generated by peroxisomal oxidase (3). 
catalase 
> 2lLp + O2 
b) Mitochondria: 
Mitochondrial H^O。is derived from dismutation of superoxide radical, O2" 
(8). 
202" + O2 
c) Cytoplasm: 
Xanthine oxidase and aldehyde oxidase are flavoproteins containing FAD, 
iron-sulfur centers and molybdenum, and can undergo redox cycling. These 
enzymes show little substrate specificity, the oxygen molecule can serve as 
substrate resulting in generation of superoxide radical ( ( ^ ) and hydrogen 
peroxide (H^O^) (9,10). 
xanthine oxidase 
Hypoxanthanine + H^O + O^ > Xanthine + H^O^ or (O^") 
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xanthine oxidase 
Xanthine + H^O + O^ > Uric Acid + H^O^ or (O^') 
aldehyde oxidase 
RCHO + H^O + O 2 - > RCOOH + H2O2 or (O^") 
d) Microsomal and Plasma Membranes: 
Microsomal and plasma membrane-associated enzymes such as 
lipoxygenase and cyclooxygenase wi l l catalyse the oxidation o f arachidonic 
acid resulting in the formation of biologically active substance such as 
thromboxanes, prostaglandins and oxygen-derived radicals (8). 
e) Plasma Membrane of Phagocyte: 
When phagocytes are exposed to appropriate stimuli, e.g. opsonized 
bacteria, flavin-containing NADPH oxidase in the plasma membrane o f 
these cells can catalyse reduction of oxygen to superoxide radical ( O ! ) at 
the expense o f NADPH. 
NADPH oxidase 
NADPH + 2O2 > 2O2-+ NADP+ + H^ 
The superoxide radical produced becomes the precursor o f a group o f 
powerful oxidants which aid in killing invading micro-organisms. This 
metabolic event is often called the oxidative or respiratory burst o f the 
phagocyte. Though these active oxidants are usually confined within the 
intracellular vacuole, some of them might leak into the extracellular 
compartment causing tissue damage and inflammation (9，11) 
iii) Non-Enzymatic Autoxidation: 
Although enzymatic production of oxygen-derived radicals described above is 
biologically important, it does not play a significant role in inducing the oxidative 
damage commonly seen in hyperoxia. This is due to the fact that most o f these 
oxygen-dependent enzymes are saturated at normal pO】. In the case o f hyperoxia, 
these reactive oxygen species are most likely coming from non-enzymatic 
autoxidation (9). 
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a) Non-Enzymatic Autoxidation of Reactive Components: 
Non-enzymatic autoxidation of reactive components produced during 
reductive processes associated with mitochondrial, microsomal and 
endoplasmic reticulum electron transport systems wil l result in production 
of superoxide. As an example, the ubiquinone-cytochrome b region o f 
mitochondria is the major site ofO^" production due to the autoxidation of 
ubisemiquinone in this region (9,10). 
O le- O 
v s — > y y 
o A o -
Ubiquinone O2 Ubisemiquinone Radical 
Membrane bound cytochromes (P450 & b5) located in endoplasmic 
reticulum wil l also generate O^'and H^Oj by autoxidation. 
b) Non-enzymatic autoxidation of reduced transition metal can also 
generate superoxide (4). 
Fe2+ + O2 > + O^" 
Cu+ + O2 > Cu2+ + O2" 
I I . Exogenous Production: 
A wide variety of exogenous drugs, chemicals and pollutants wil l promote 
ROS production. Drugs and chemicals are capable of enzymatic reduction and O】. 
generation on autoxidation. Examples include herbicidal paraquat, adriamycin, 
bleomycin, streptonigrin, dialuric acid, nitrofurantoin and related compounds 
(9,10). 
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— P H 、 ( P Q ^ ^ ^ ^ 
Enzyme V 
— P + ^ ^ PQ+ O2 
PQ=paraquat 
Irradiation of the organism with electromagnetic radiation wil l generate 
primary radicals such as e", OH. and H*. These might further react with O^ forming 
O^". In addition, various environmental agents such as cigarette smoke, air 
pollutants, halogenated hydrocarbon, organic solvents and pesticides wi l l directly 
cause free radical damage. They might readily form free-radicals or be converted to 
free-radical species by interacting with intracellular metabolism (8). 
2.2.5 Generation of Hydroxy Radical (0H') through H^O^ and O^ 
Most of the hydroxy radicals generated in vivo, except during excessive 
exposure to ionizing radiation (which brings about the homolytic fission of water 
resulting in OH* generation) comes from reaction of transition metal ions with 
H2O2 according to the general equation as follows (12): 
Mn+ + H2O2 > M _ ) + + OH- + OH" 
In vitro the metal could be any transition metal but the best candidate for promoting 
OH- formation is ferrous ion (Fe2+) and to a small extent cuprous ion (Cu+). These 
appear to be more reactive with H^O^ than their oxidized counterparts ferric (Fe^"^ 
and cupric (Cu2+) respectively. Specifically, the Fe^"^-dependent decomposition of 
H^O^ is called the Fenton reaction (12). Nevertheless it has been shown that OH. 
radical formed in this system is usually inhibited by superoxide dismutase (SOD) 
and catalase. I t is not surprising that catalase acts to inhibit the process since OH. 
arise from the metal-dependent decomposition of H^O】. The observed inhibitory 
action of SOD thus suggested that O^" and H^O^ interact to form the highly-
reactive hydroxy radical which was postulated by Haber & Weiss (1934) and was 
known as the Haber-Weiss reaction (12). This reaction is less likely to occur 
spontaneously in biological systems due to the low-steady concentration of Oj" and 
H^Oj in vivo. I t had been shown that transition metals as discussed above act as 
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catalysts in promoting the reaction, the mechanism can be written as follows: 
(taking iron as an example) 
Fe3+ + ( Y >Fe2+ + 0】 
PQ2+ + H O - >Fe3+ + O H . + O H " (Fenton Reaction) 
Fe-salt catalyst 
net: CY + H2O2 >02 + 0 H + 0 H -
The net reaction is called a metal-catalysed Haber-Weiss reaction or a superoxide-
driven Fenton reaction i f iron is the catalyst involved (7，12). Hydroxy radical wi l l 
be site specific to the point at which metal promoters are located, it is an extremely 
active specie that wil l react with most biomolecules and cause great damage within 
a small radius of its production. 
I t is clear from the above discussion that the "active" players in free radical 
biochemistry are oxygen, O^', H】。!，transition metal ions and the hydroxy radical. 
The first four take place in a variety of reactions to generate the last, which is 
comparatively the more dangerous species (4). Hydroxy radical can damage a wide 
range of biomolecules such as protein, thiols, nucleic acids and probably also 
initiate the process of lipid peroxidation. An additional point concerning the role of 
transition metals is that free radical reaction in vivo may often be limited by 
availability of transition metals. Thus O^" and H^O^ at physiologic concentration 
may have limited damaging effects i f no catalytic metal ions are available (13). 
2.3 Free Radical Damage and Lipid Peroxidation 
All the major classes of biomolecules may be attacked by the free radicals, 
with lipid being most susceptible. Polyunsaturated fatty acid (PUFA), being a major 
component of cell membranes, is readily attacked by oxidizing radicals due to the 
presence of a double bond C:C=C<) which weakens the C-H bond on the carbon 
atom adjacent to the double bond. Oxidative deterioration of PUFA is known as 
lipid peroxidation and proceeds as a self-propagating chain reaction. Protein and 
nucleic acid appear to be less susceptible to free radical damage due to the unlikely 
occurrence of a rapid destructive chain reaction. For damage to be significant, it 
should be site-specific and of high intensity (4). 
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Lipid peroxidation is defined as a free radical initiated chain reaction that 
causes oxidative deterioration of polyunsaturated fatty acid . Three distinct phases 
are identified in this chain reaction namely, the initiation phase, propagation phase 
and termination phase (3,9,14,15). A free radical (R.) that has sufficient energy to 
abstract a hydrogen atom from the methylene group (-CH^-) in polyunsaturated 
fatty acid (LH) can initiate the chain peroxidation process. OH* radical and the 
protonated form of O^", HOO* can certainly do this while is insufficiently 
reactive to abstract H^ from lipid. Abstraction of H^ from the -CH^- group in 
polyunsaturated fatty acid (LH) wi l l result in formation of carbon-centered radical 
(L-) 
L H + R. > L - + R H I N I T I A T I O N STEP 
The resulting carbon-centered radical (L.) tends to be stabilized by molecular 
rearrangement to form conjugated diene which under aerobic conditions is most 
likely combined with O^ to give peroxyl (peroxy) radical, (LOO*). Peroxy radical is 
capable of abstracting H^ from another polyunsaturated fatty acid group (L'H) 
forming lipid peroxide (lipid hydroperoxide), thereby setting in motion an 
uncontrolled chain reaction, the propagation phase 
L. + O2 > LOO-
peroxyl radical PROPAGATION STEP 
(peroxy) 
LOO- + L'H- > LOOH + L'* 
lipid peroxide (lipid hydroperoxide) 
Furthermore, the reaction may be accelerated because the hydroperoxide products 
themselves are a potential source of further radicals such as alkoxyl or peroxyl 
radicals through transition metal ion-catalysed decomposition e.g. by Fe, Cu 
LOOH + Fe2+ > LO. + Fe^"^ + OH" 
alkoxyl radical 
LOOH + Fe3+ > LOO. + Fe^"^ + it 
peroxyl radical 
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In the presence of a metal catalyst, hydroperoxide can also be decomposed to a 
variety o f end products, such as cytotoxic aldehydes including malondialdehyde 
(MDA), alkanals, alkenals, 4-hydroxyalkenals and alkadienals. Other decomposition 
products include small chain hydrocarbons such as ethane and pentane. Many o f 
these are biologically active and can diffuse from the original site o f attack and 
spread the damage to the other part of the cell. As shown below the chain reaction 
can be terminated when i) two free radicals meet to yield a non-radical product or 
i i) when the radical is scavenged by a variety of different antioxidants (A). In 
general, the antioxidant radical (A') is a less reactive and less damaging free radical 
species. 
i) when radical meets radical: 
L - + L * > L L 
LOO. + LOO- > LOOL + O^ 
L O O + L . > LOOL 
T E R M I N A T I O N STEP 
ii) scavenger system: 
L- + A:H- > L H + A. 
antioxidant antioxidant-derived radical 
LOO. + A : H > LOOH + A. 
‘ / 
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Figure 2 illustrates the overall mechanism of lipid peroxidation (3,4). 
Figure 2; Simplified Scheme of Lipid Peroxidation 
I) INITIATION STEP: 
L H + R. > L. + R H 
PUFA Free Carbon 
Radical Centered 
Radical 
II) PROPAGATION STEP: 
L + O2 > LOO. 
Peroxyl (Peroxy) Radical 
LOO* + L,H > LOOH + L丨• 
Lipid Peroxide 
(Lipid Hydroperoxide) 
^ ^ ^ ^ ^ ^ ^ ^ 
a) Metal-Dependent Decomposition b) Lipid Hydroperoxide 
o f Lipid Peroxide: 、， 
Cyclic Peroxide 
LOOH + Fe2+---> Fe^"^ + OH" + LO* Cyclic Endoperoxide 
Alkoxyl 
(Alkoxy) Both Cyclic Peroxide and Cyclic 
碰 c a l Endoperoxide wi l l be 
^. . fragmented to aldehydes 
LOOH + Fe2+ + H^ + LOO. (including malonaldehyde), 
Peroxyl ^ , . . , •；， ” 
(Pero^) polymerization product or small 
Ratiical chain of hydrocarbon such as 
ethane and pentane. 
Both Alkoxy and Peroxy Radicals act 
to initiate new chain reaction 
m) TERMINATION STEP: 
a) when radical meets radical: b) scavenger system: 
L- + L- > L L L. + A : H > A . + L H 
LOO* + LOO* > LOOL + O ! antioxidant antioxidant-derived 
LOO. + L. > LOOL radical 
LOO.+ A : H > L O O H + A. 
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Lipid Peroxidation is of particular significance as a damaging reaction 
consequent to free radical production. I t wil l damage both the lipid and protein 
component of the membrane or lipoprotein. The process itself wi l l deteriorate the 
lipid component, however, the variety of compounds produced in the peroxidation 
process such as alkoxyl radical, peroxyl radical, carbon-centered radical, 
malonaldehyde, aldehyde wil l attack specific groups in protein leading to the 
deterioration of the protein entity. In general, the overall damage is as follows: 
(10,16) 
i) Crossing-linking and decreased fluidity of membranes essential for 
proper function. 
ii) Damage to structure-function activity of the membrane. 
iii) Increase in leakiness of the membrane and complete loss o f 
membrane integrity. Rupture of the membrane say in case of 
lysosome, might lead to the leakage of hydrolytic enzyme and thus 
amplify the damage. 
iv) Formation of biologically active products result in diffusion of the 
damage. 
V) Oxidation of lipoproteins in plasma which might play a role in the 
pathogenesis of atherosclerosis. 
2,4 Lipid Peroxidation and Atherosclerosis 
Atherosclerotic lesions tend to form in areas of the vascular tree that are 
subject to injury, usually mechanical injury. Endothelial injury is thought to be an 
important initiating event in atherogenesis. After the injury, clusters of monocyte-
derived macrophages from the circulation begin to penetrate beneath the 
endothelium becoming foam cell by ingesting, hydrolyzing and re-esterifying 
cholesterol ester present in LDL. As the disease progresses, most of the cell dies, 
generating the fatty streak. The endothelium over the foam cell starts to retract and 
sometimes exposes the underlying foam cells to the circulation. This results in 
adherence of platelets with mural thrombus formation, leading to hyperplasia of 
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smooth muscle cells and eventual conversion of the fatty streak into the 
proliferative lesion (17). 
I t is noteworthy that native L D L uptake by the classical L D L receptor on 
macrophage or other body cells is subject to down-regulation by intracellular 
cholesterol concentration. I t has so far proved impossible to transform monocytes 
into foam cells simply by exposing them to native L D L in vitro. That is how the 
concept o f oxidation o f L D L came into place, L D L particles are not only rich in 
cholesterol but also PUFAs and are known to be highly susceptible to lipid 
peroxidation and thus are protected by the presence o f several antioxidants. 
Vitamin E is by far the most abundant antioxidant in LDL , an average o f seven 
molecules o f this antioxidant are present in each L D L particle. Oxidation o f L D L 
occurs as a lipid peroxidation chain reaction driven by free radicals. Aldehyde 
derived from peroxidized lipid had been shown to act upon the s-amino group o f 
lysine residues on the apolipoprotein B moiety o f the L D L particle. These newly 
formed aldehyde-modified apolipoprotein B no longer bind to the native L D L 
receptor, instead they are taken up by the scavenger receptor on macrophages 
which “ not down-regulated by local cholesterol concentration. Massive 
accumulation o f cholesterol occurs in macrophages exposed to oxidatively modified 
L D L (oxLDL) leading to formation of the foam cell. In foam cell formation, the 
whole range o f biologically active compounds released by oxLDL deposited in the 
arterial wall wi l l cause irritation o f endothelium and provoke other effects that 
contribute to the development o f the lesion (18,19). 
Wi th the strong suggestion that oxidative modification o f L D L may play an 
important causative role in the pathogenesis o f atherosclerosis, increased dietary 
intake o f antioxidants which prevent the peroxidation o f lipid in vivo may inhibit the 
development o f this disease. However the mechanism of L D L oxidation in vivo is 
still largely a matter o f speculation at present. In order to be more precise about the 
type of antioxidant to be used preferentially, preventive or chain-breaking 
antioxidant or both, a deeper and further search into how and where L D L oxidation 
is initiated in vivo should be carried out (18,20). 
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2.5 Antioxidant 
Antioxidant is defined as "any substance that when present at low 
concentration compared to those of an oxidizable substrate, significantly delays or 
inhibits oxidation of that substrate" (3,21). Antioxidants protect the lipid and other 
biomolecules from free-radical mediated oxidation. I t is only when the free radical 
load exceeds the capacity of the defence system that damage can occur. The 
efficiency of the defence system in turn depends on an adequate intake of nutrient 
with antioxidant function. Antioxidant can act upon any stage of the free-radical 
chain reaction and they can be divided into three categories according to their 
function: 
i) Primary preventive antioxidants wil l suppress the generation o f free 
radicals that primarily initiate the chain reaction (15,22). 
ii) Secondary radical-scavenging antioxidants directly scavenge the 
active radical, thus inhibiting chain initiation and/or break the chain 
propagation (15,22). 
iii) Repair and de novo antioxidants involve those enzymes that are 
capable of repairing the damage or removing the damaged 
biomolecule before their accumulation might alter cell metabolism or 
viability. For example, phospholipases wil l repair oxidatively 
damaged phospholipids; proteolytic enzyme will recognize, degrade 
and remove oxidatively-modified protein; nucleases wil l repair 
damaged D N A (15,22). 
i 
In the following, I would like to concentrate on how the preventive and radical-
scavenging antioxidants act against lipid peroxidation. 
2.5.1 Primary preventive Antioxidants 
Preventive antioxidant can act through various mechanisms: 
i) Since hydrogen peroxide and lipid hydroperoxide are important precursors of free 
radicals which in turn initiate the peroxidation process, some of the preventive 
antioxidants will act to decompose these peroxides to alcohol and water without 
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generation of free radicals. Examples include glutathione peroxidase, peroxidase 
and catalase. 
a) Glutathione peroxidase is a selenium-containing enzyme located in the 
cytosol and mitochondrial matrix of many cells which catalyzes oxidation o f 
glutathione (GSH) to oxidized glutathione (GSSG) at the expense o f 
hydrogen peroxide (H^O^) or lipid hydroperoxide (LOOH) (3,14,15). 
glutathione 
peroxidase 
H2O2 + 2GSH > 2H2O + GSSG 
glutathione oxidized glutathione 
glutathione 
peroxidase 
L O O H + 2GSH > L O H + GSSG + H^O 
lipid lipid 
hydroperoxide aldehyde 
b) Peroxidase acts to remove hydrogen peroxide and lipid hydroperoxide 
intracellularly (14,15). 
peroxidase 










c) Catalase is an iron-containing enzyme found in peroxisomes that 
catalyzes the decomposition of hydrogen peroxide (14,15). 
catalase 
2H2O2 > 2H2O + O2 
ii) Transition metal ions play an important role in the formation o f free radicals 
capable o f inducing chain reactions. Binding the transition metal wi l l consequently 
reduce free radical generation. Proteins such as transferrin, ferritin and lactoferrin 
wi l l sequester iron while ceruloplasmin wil l sequester copper (14,15,22). Besides 
non-specific binding of copper by ceruloplasmin, it has a ferroxidase activity which 
could oxidizes Fe^"^ to Fe^"^ which is less able to catalyse the Fenton reaction. 
4Fe2+ + O2 + > 4Fe3+ + 
The haem-containing proteins myoglobin and hemoglobin are powerful stimulators 
o f peroxidation because they contain the transition metal iron. The hemoglobin-
binding protein haptoglobin, as well as the haem-binding protein haemopexin, wi l l 
diminish the effectiveness of these iron compounds in stimulating lipid peroxidation 
(21). 
i i i) Superoxide is not highly active itself but is capable o f reducing iron (IH) to 
active iron (I I) which then participates in the metal-catalysed Haber-Weiss Reaction 
for generating highly active OH. species. Besides, it may be protonated to yield the 
hydroperoxyl radical, HOO.. Both of these radicals are sufficiently active to initiate 
the lipid peroxidation reaction (14,15,22). Superoxide dismutases, a manganese-
containing enzyme in mitochondria and a copper-zinc containing enzyme in the 
cytoplasm, wi l l catalyze the dismutation of superoxide radical to hydrogen 
peroxide, reducing the amount o fO^ ' as indirect precursor of lipid peroxidation (3). 
Cu/Zn; Mn 
superoxide dismutase 
O2" + O^' > H2O2+O2 
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2.5.2 Secondary Radical Scavenging Antioxidants 
Although most of the generation of free radicals in vivo wil l be hampered by 
the primary preventive antioxidant system, a small amount of free radical derived 
endogenously or exogenously could still be present, and wil l be actively scavenged 
by secondary radical scavenging antioxidants (4). The radical scavenging 
antioxidant can be either hydrophilic or lipophilic and its general action is illustrated 
by the following equation: 
X- + A H > X H + A-
free antioxidant antioxidant-
radical derived radical 
To be an efficient radical-scavenging antioxidant, it must scavenge free radicals 
quickly while itself turning into a relatively stable antioxidant-derived radical 
incapable of inducing another chain reaction (22). 
n Lipid Soluble Radical-Scavenging Antioxidants: 
a) Vitamin E is a term that encompasses a small group of related 
tocopherols. There are four types of tocopherol, namely a, p, y, 5 with a 
tocopherol being the most biologically important. Nowadays "a-
tocopherol" and "vitamin E" are used interchangeably in most literature (3). 
Vitamin E is the most important lipophilic radical-scavenging antioxidant. I t 
tends to concentrate in the interior of membranes, in blood lipoproteins and 
in the adrenal gland. Its major antioxidant action is to react with the lipid 
peroxy and alkoxy radical within the lipid compartment, thus terminating 
the chain reaction (3). 
LOO. + T H > LOOH + T 
(a-tocopherol-OH) (a-tocopherol-0.) 
LO. + T H > LOH + T. 
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The resulting tocopherol radical T* is fairly unreactive; it can react with a 
second radical or itself to form a stable product, or more importantly can be 
converted back to tocopherol by vitamin C (ascorbate) as shown below: 
T* + ascorbate > semidehydroascorbate + T H 
The resulting semidehydroascorbate radical is not particularly reactive and 
wi l l undergo a disproportionation reaction to form dehydroascorbate. 
2 semidehydroascorbate > ascorbate + dehydroascorbate 
Dehydroascorbate reductase can act on either semidehydroascorbate or 
dehydroascorbate for conversion of these oxidized form of ascorbate back 
to the reduced form (3). 
2 semidehydroascorbate + 2GSH ——> GSSH + 2 ascorbate 
dehydroascorbate + 2GSH ——> GSSH + ascorbate 
Another possible means of removing the tocopherol radical is reaction with 
ubiquinol, a reduced form of coenzyme Q (CoQH^). In mitochondria, the 
resulting CoQH* can be recycled by the electron transport system of 
mitochondria (13). 
r + C0QH2 > T H + CoQH. 
b) Carotenoid is also known to act as an antioxidant. Most attention has 
been given to P-carotene which is one of the most potent "quenchers" o f 
singlet oxygen, converting singlet oxygen to ground-state oxygen. Beta-
carotene can also function as a peroxyl radical scavenger. However, it is 
present in relatively low levels in tissue compared to a-tocopherol (23). 
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TT) Water Soluble Radical-Scavenging Antioxidants 
Vitamin C, uric acid, bilirubin, albumin and thiol compounds are all included 
in this category. They can only scavenge aqueous free radicals and cannot scavenge 
the lipophilic radicals within membrane and lipoprotein. 
a) Vitamin C: I t can scavenge a variety o f reactive free radicals including 
O^-, HOO-，OH-, ROO•，thiyl and sulphenyl radicals as well as singlet 
oxygen and hypochlorous acid HOCl, a powerful oxidant produced by the 
enzyme myeloperoxidase in activated phagocytic cells. I t is capable o f 
regenerating a-tocopherol at the surface of membranes by reducing a -
tocopheryl radicals. However, it appears that a mixture o f ascorbic acid and 
iron or copper salts has powerful prooxidant properties. This is in turn due 
to the fact that ascorbate, like O^", can reduce Fe(m) to Fe(n), which could 
then take part in the metal-catalysed Haber-Weiss Reaction generating 
dangerous OH. radicals. Indeed all the reported prooxidant properties of 
ascorbate probably involve its interaction with transition metal ions. 
Provided that the free transition metal are safely sequestered by plasma 
protein, ascorbic acid can then exert its antioxidant activity more effectively 
(3). 
b) Uric acid: I t accumulates as an end product of purine metabolism and is a 
powerful scavenger o f singlet oxygen, peroxy radical and hydroxy radical, 
thus functioning as an antioxidant in vivo. However, like vitamin C, it is not 
always a perfect antioxidant. In the process of scavenging oxidizing species 
such as OH. radical, uric acid radicals are generated which most likely wi l l 
react with O . to give peroxyl radicals. These radicals can inactivate certain 
L i 
enzymes such as human a-antiproteinase (3). 
\ \ 
R-C-H + OH- > R - C + H，0 
/ / 2 
uric acid radical 
R - C +O2 >R-〉00. 
peroxyl radical 
Fortunately, these uric acid radicals can be reduced by ascorbic acid (21). 
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c) Plasma protein: Albumin is a powerful scavenger of hypochlorous acid 
(HOCl) forbidding the access of this powerful oxidant to other more 
important targets. Moreover, it can bind copper ions and play a role in 
inhibiting copper-dependent lipid peroxidation and OH* radical formation 
(3). Sulfhydryl groups of the plasma protein are powerful scavenger of 
peroxy radicals (3). 
d) Bilirubin: The bile pigments bilirubin and biliverdin produced by heme 
catabolism and transported by albumin in plasma are effective singlet 
oxygen quenchers, protecting albumin-bound fatty acid against peroxidation 
in vivo (21). 
e) Thiols: Thiol groups act as intracellular antioxidants by scavenging free 
radicals and through some enzymatic reactions. Glutathione is the most 
important cellular thiol, acting as a substrate for H^O^-removing glutathione 
peroxidase and for dehydroascorbate reductase in regeneration of ascorbate. 
I t is also a powerful scavenger of OH* radicals and singlet oxygen (3). 
2 6 Measurement of Oxygen-Derived Radical in Vivo 
With increasing interest in the role of free radicals in the pathogenesis of 
human disease, there is clearly an important need for techniques to measure free 
radicals and their reaction in vivo. However, direct measurement of free radicals is 
very difficult since these species are very reactive and short-lived, and are likely to 
react at or close to their site of formation. Their chance of being detected in the 
readily accessible body fluid distant from the locus of original production is low. 
That is why free radical activity is usually assessed by indirect measurement of the 
end product formed during its reaction with cellular components such as lipid, 
protein and DNA. The techniques currently available for measuring free radicals in 
vivo are limited to semi-quantitative assays that monitor the oxidative damage done 
to various class of biomolecules. More specific and sensitive methods need to be 
derived so as to gain more insight into the role of free radicals in a wide variety of 
related disorders. I t is hard to say which is the method of choice for measuring free 
radicals in vivo as each method measures something different. To use them 
intelligently, one has to think carefully about what is actually measured in each 
method and how it relates to the overall process of lipid peroxidation, DNA and 
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protein oxidation. Assay of oxidative damage is better coupled with simultaneous 
clinical assessment during the illness or after initiation of antioxidant therapy. This 
allows us to unravel their inter-relationship (6,24). 
Figure 3 shows an overview of methods for determining the involvement of 
oxygen-derived radical in vivo (3,6,24). 
Figure 3; An Overview of Methods for Determining the Involvement of 
Oxygen-Derived Radical in Vivo 
7) Direct Method 
Method Principle of Method 
a) Electron Spin Resonance ESR will measure the paramagnetic property of 
radicals, it requires the addition of a compound 
called spin trap which will react selectively with 
the radical of interest producing a more stable, 
longer-lived radical, rendering it suitable for 
measurement (24). 
b) Chemiluminescence Method Luminol is oxidized by Reactive Oxygen 
Species to an electronically excited state, photon 
is emitted when the excited state return to the 
ground state. Emission is characteristically 
around 450nm (6). / 
77) Indirect Method 
Method Principle of Method Comment 
a) Measurement of Lipid 
Peroxidation Product 
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• Conjugated Diene Assay Oxidation of unsaturated It is a useful index of lipid 
fatty acid is accompanied by peroxidation. However, 
formation of conjugated many other substances 
diene which absorb UV present in the biologically 
light in the range of 230- material such as haem 
235nm (24). protein, purine and 
pyrimidine also absorb 
strongly in the UV region 
and create a high 
background signal. This 
could be eliminated by 
extraction of conjugated 
diene into an organic 
solvent before measurement 
• Measurement of Lipid Hydroperoxide is the major Accurate measurement of 
Hydroperoxide initial molecular product of hydroperoxide is difficult 
lipid peroxidation and can because of their rapid 




• TEARS assay (ThioBaibituric Small amount of The test is very simple and 
Acid Reactive Substance) malonaldehyde are formed quick. However, it is non 
during lipid peroxidation specific for malonaldehyde. 
and can react with TEA To improve specificity, the 
under acidic condition to MDA-TBA adduct can be 
generate a pink color measured by HPLC and GC 
product that absorb light at or sample extraction carried 
532 nm (24). out before measurement (3). 
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• Measurement of Aldehyde other The aldehyde are These technique are 
than Malonaldehyde (MDA) derivatized with generally extremely time-
dinitrophenylhydrazine consuming and quite 
(DNPH) to be separated by expensive. It is unlikely to 
TLC. The individual be used as routine measure 
aldehyde can then be of lipid peroxidation (24) 
assayed by HPLC with UV 
detection (24). 
• Measurement of Ethane and Trace volatile hydrocarbons A high background signal 
Pentane in Expired Breath such as ethane and pentane because the air we are 
are produced by breathing now is commonly 
peroxidation of n-3 and n-6 contaminated with 
fatty acid in vivo. These hydrocarbons from motor 
volatile gas can be vehicle. It is non-specific 
measured in the exhaled since intestinal bacteria may 
breath of human by GC produce significant amount 
with a flame ionization of hydrocarbon in vivo (24). 
detection (24). 
• Measurement of Fluorescent Caitwnyl compound such as It is non-specific since 
Products of Lipid Peroxidation malonaldehyde can react fluorescence can also 
with primary amino group develop when DNA and 
in protein, free amino acid, protein are subject to 
phosphatidylethanolamine oxidative damage (24). 
or with nucleic acid bases to 
produce fluorescent 
products known as schiff 
bases. Fluorescent product 
can also be produced by 




b) Measurement of Protein 
Damage 
• Amino Acid Aldehyde During oxidative attack on Oxidatively damaged 
protein, free radical will protein are readily removed 
react with amino side group by protease rather than 
of the protein resulting in accumulate to readily-
the generation of caibonyl detectable level in normal 
group. The caibonyl content biological material (3,24). 
of oxidatively modified 





• Measurement ofKynurenines When tryptophan and Same as above (6). 
and Bityrosine tyrosine are subject to 
Reactive Oxygen Species 
attack, kynurenines and 
bityrosine are formed 
respectively and can be 
measured by HPLC (6). 
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c) Measurement of D N A 
Damage 
拳 Measurement of Oxidized Bases Free radical such as OH' 
can irreversibly damage 
DNA base. The major 
product of OH. with 
thymine is thymine glycol 
and with guanine, 8-
hydroxyguanine. These 
oxidized DNA bases will be 
excreted in the urine either 
as free base products or as 
the nucleoside derivatives, 
thymidine glycol and 8-
hydroxydeoxyguanosine. 
These product could be 
quantitated by HPLC (24). 
d) Measurement of Radical-scavenging 
Antioxidant antioxidant are consumed 
during oxidative stress, 
TRAP assay which measure 
the capacity of peroxyl 
radical scavenging 
antioxidant in plasma will 
indirectly reflect the free 
radical activity in vivo (24). 
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2.7 Principle of the TRAP assay 
The extracellular body fluids, including plasma, are very effective in 
combating radical-initiated lipid peroxidation. This is due to the presence o f primary 
preventive antioxidant and secondary chain-breaking antioxidants extracellularly. 
Transferrin, lactoferrin, ceruloplasmin, haptoglobin and haemopexin, the major 
primary preventive antioxidants, wi l l bind metal ions in a safe form that wi l l not 
stimulate free-radical reactions. Chain-breaking antioxidants help to scavenge 
radicals and consequently prevent the initiation and/or propagation o f radical chain 
reaction (21). 
Ingold and co-workers (25,26) had attempted to define the nature and 
magnitude o f the secondary chain-breaking antioxidants in plasma by establishing 
the TRAP assay based on the ability o f plasma antioxidants to trap the peroxyl 
radicals produced in vitro, and consequently to reduce the rate o f oxygen 
consumption during lipid peroxidation. "TRAP" is defined as the "Total (peroxyl) 
Radical-trapping Antioxidant Parameter" and it measures the amount o f peroxyl 
radicals that can be scavenged (^imol per litre o f plasma), an estimate o f the 
secondary chain-breaking antioxidant capacity. The oxygen consumption method 
utilizing the oxygen electrode is a time consuming technique, taking 90 mins to 
measure one sample. Recently, workers in Birmingham and in Finland (27) have 
described methods to measure TRAP based on the ability o f plasma antioxidants to 
quench peroxy radical generated chemiluminescence. Thumham and Coll (1) have 
combined and modified these to produce the method that was established in this 
project. A more detailed protocol of this method was also received from Professor 
D.I . Thumham o f the University o f Ulster, Coleraine, Northern Ireland (28). 
Basically, the principles behind the oxygen consumption method and the 
chemiluminescence method for the measurement o f TRAP have very much in 
common. They only differ in the detection system. Both methods are designed to 
reproduce lipid peroxidation in vitro in the presence of ABAP (azo-bis(2-
amidinopropane)hydrochloride). ABAP is a water-soluble thermolabile azo 
compound that decomposes at 37。C to give free carbon-centered radicals (R.) at a 
constant rate. These free radicals (R') has sufficient energy to initiate the chain 
peroxidation process by abstracting hydrogen atoms from the methylene groups (-
CH j - ) present in the linoleic acid, the oxidizable lipid present in reaction mixture. 
The lipid radicals generated wi l l then consume O^ in the medium forming peroxyl 
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radicals which are capable of setting in motion an uncontrolled chain reaction. The 
process that takes place in the reaction mixture is shown in Figure 4 (4). 
Figure 4; Process in Reaction Mixture 
I) INITIATION STEP: 
37。C 
RN=NR > N^ + 2R-
temperature-controlled rate carbon-centered 
CH3 CH3 radical 
CI H^ N=C- C--N=N--C—C--NH2 CI 
¥ CH3 CH3NH2 
ABAP 
L H + R. > L- + R H 
linoleic caibon-centered lipid-derived 
acid radical radical 
II) PROPAGATION STEP: 
L- + O2 >L00 -
peroxyl (peroxy) radical 
LOO. + L 'H > L O O H + L " 
linoleic acid lipid peroxide 
(lipid hydroperoxide) 
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2.7.1 Oxygen Consumption Method 
In the oxygen consumption method, peroxyl radical initiated lipid 
peroxidation of linoleic acid is accompanied by rapid consumption of oxygen. The 
rate of oxygen uptake is monitored by the oxygen electrode. This stage is called the 
propagation phase with a steep slope . However, with the addition of plasma which 
possesses the peroxyl radical-scavenging capability, lipid peroxidation is inhibited 
resulting in a decrease in oxygen consumption. This is the induction phase with a 
gentler slope. The duration of the induction phase is directly proportional to the 
total peroxyl radical-trapping capacity of plasma (29). TRAP of the plasma can be 
quantitated by comparing the duration of the induction phase to the duration 
produced by a known quantity of an antioxidant with a known stoichiometric 
factor. This factor represents the number of peroxyl radicals that could be trapped 
per molecule of the antioxidant. Trolox, a vitamin E analogue with a stoichiometric 
factor of 2, is used commonly as the standard in the quantitation of TRAP (25,26). 
Figure 5 illustrates clearly what happen in the oxygen consumption method for 
measuring TRAP. 
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Figure 5; Oxygen Consumption Method 
丫 Plasm* 
2 . 1 
100 • 
•。: H ^ ^ ^ 
so . i 玄 \ Y Tfolox V 
40 . s in \ 
. I 1. \ 
o o \ 
" ： ‘ ^ \ 
° • 0 30 60 90 120 ISO 
Time (min) 
Source: (29) Lindeman J.H.N.et al. "The Total Free Radical Trapping Abil i ty o f 
Cord Blood Plasma in Preterm and Term Babies". Pediatric Research. 1989;26(1): 
20 
"T" plasma - duration o f induction phase produced by unknown plasma. 
"T"Trolox - duration of induction phase produced by the internal standard 
Trolox 
f- dilution factor 
Formula for calculation: / 
(when the volume of unknown plasma and trolox standard used are the same), 
T plasma 
TRAP (^mol/L) 二 2 x [Trolox] x x f 
T Trolox 
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2.7.2 Chemilumimscence Method 
In the chemiluminescence method, peroxyl radicals can both initiate lipid 
peroxidation of linoleic acid and also oxidize luminol to emit chemiluminescence. 
This stage is the propagation phase with steady emission of chemiluminescence. 
0 0 
II 丨丨— 
R 0 0 . + I ^ J h ——> L A c —o- + N 2 + U g h t a t 4 2 5 n m 
T II 丨 H 
NH, 0 NH, 0 
luminol a-aminophthalate 
However, with the addition of plasma which exhibits antioxidant capacity by 
trapping peroxyl radical, the lipid peroxidation process is inhibited as is the peroxyl 
radical generated chemiluminescence. This is the induction phase. When the peroxyl 
radical-trapping capacity of plasma is exceeded, this is again followed by the 
propagation phase with steady emission of chemiluminescence. Similarly to the 
oxygen consumption method, the duration of the induction phases produced by 
plasma and Trolox are employed in calculating the TRAP value. Figure 6 illustrates 
the chemiluminescence process graphically. 
31 
Figure 6; Chemiluminescence Method 
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"T" Trolox "T" Trolox "T" plasma 
Time (mins) 
"T"plasma - duration of induction phase produced by unknown plasma. 
"T"Trolox _ duration of induction phase produced by the internal standard 
Trolox 
f- dilution factor 
Formula for calculation: 
(when the volume of unknown plasma and trolox standard used are the same) 
T plasma 
TRAP (^imol/L) = 2 x [Trolox] x x f 
T Trolox 
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The "TRAP" assay provides a mean of measuring the secondary chain-
breaking antioxidant capacity of extracellular fluid. I t is only one o f the many 
mechanisms whereby antioxidants protect the body from oxidative stress. I t had 
been shown by Wayner et al (26) that vitamin E, urate, ascorbic acid and protein 
(due mainly to the presence of sulfhydryl groups) wi l l account for all the TRAP 
activity in the majority of human plasma. I t is generally recognized that vitamin E is 
lipophilic and can only trap peroxyl radicals that diffuse or are at the interface of a 
lipid phase. Urate, ascorbic acid and protein sulfhydryl groups wi l l trap peroxyl 
radicals in the aqueous phase but not the lipid phase. The relative contribution o f 
each o f these to the TRAP value in plasma is as follows: urate (35-65%), plasma 
protein (10-15%), ascorbate (0-24%) and vitamin E (5-10%) (26). Exposure o f the 
plasma to the aqueous peroxyl radicals generated in the reaction mixture wi l l lead 
to the immediate oxidation of ascorbate and sulfliydryl groups followed by 
depletion o f urate and finally vitamin E. I t is recognized that vitamin E remains 
detectable until the very end of the induction phase due to the ability o f vitamin C 
to regenerate vitamin E from the a-tocopherol radical. In addition to the direct 
measurement of TRAP using the two methods described above, TRAP value could 
be calculated when the concentration of each of the contributing antioxidant and its 
stoichiometric factor (number of peroxyl radicals trapped by each molecule of this 
antioxidant) are known. For the oxygen consumption method, the formula is as 
follows (30): 
TRAP (calculated)^ 2 [Vit E ] + 1.7 [Urate] + 1.5 [Ascorbate] + 0.20 [SH] 
While for the chemiluminescence method, the formula is as shown (1): 
TRAP (calculated): 2 [Vit E] + 1.7 [Urate] + 1.5 [Ascorbate] + 0.45 [SH] 
From the above formulas, stoichiometric factors for the main plasma antioxidants 
are the same for the two methods except for the protein sulfhydryl groups. 
According to Coll and Thumham (1)，this probably represents the greater efficiency 
of protein sulfhydryl groups for trapping peroxyl radicals in the chemiluminescence 
system. 
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Chanter lU: Materials and Methods 
3.1 Instrumentation and Materials 
Chemiluminescence determinations were made on an LKB Wallac 1251 
luminometer connected to a LKB Wallac 2210 chart recorder (Bio-Orbit Ltd). 
Reagent Preparation and Suppliers: 
i) phosphate-buffered saline (PBS) PH 7.4 at 25。C (home-made): 
7.012gNaCl; 0.201gKCl; USGgNa^HPO^; OJlSgNaHy^CV 
2 H p in 1 litre of distilled water 
ii) 2,2' - azo-bis [2-amidinopropane hydrochloride] (ABAP, 
Polysciences Ltd., Northampton): 600 mg in 5 mL PBS; prepare 
freshly 
iii) sodium linoleate (Sigma): 9.45 mg in 5 mL PBS; stored in brown 
vials at -70。C 
iv) sodium perborate (Merck): 10 mg in 25mL PBS; prepare freshly 
V) Dimethyl Sulphoxide (DMSO, Sigma) 
vi) Luminol (Sigma): 17.7 mg in 50 mL DMSO; prepare freshly 
vii) Trolox (Vitamin E analogue: 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic; Aldrich Chemical Ltd, London): 
0.2 mmol/L; separated into aliquots and stored at -70°C 
3.2 Method 
2. J Establishment of the Chemiluminescence Method for Determination of TRAP 
The chemiluminescence method for measurement of TRAP was as described 




The luminometer was switched on and the temperature set to 37°C. I t was 
left on for 1 hour before use to allow stabilization of temperature. For monitoring 
the continuous light output from the luminometer, it was connected to a L K B 
Wallac 2210 chart recorder and was set on "continuous recording" mode. Chart 
speed on the recorder was set at 10 mm/min and the zero-line adjusted (input from 
luminometer was set at 500 mV or I V ) before sample preparation. Manual ranging 
o f the light output from the recorder was achieved by pressing "Signal" and 
"Down" buttons on the luminometer simultaneously when a fresh sample was within 
the measuring chamber and being read. The luminometer cover was firmly closed 
during measurement. 
II、Preparation of Sample before Analysis 
The plasma was diluted 1:5 with phosphate-buffered saline and 
ABAP/sodium perborate mixture was prepared sufficient for two measurements 
(400 \ iL ABAP + 100 ML sodium perborate + 100 j iL PBS). 
I IP Manual Operation of the Chemiluminescence Method 
The cuvette was placed in the loading position and the position counter 
reset by pressing "position" and "reset" buttons so that the loading position became 
position number 1. The following reagents were added to the cuvette in the order: 
400 fxL PBS; 200 ^iL ABAP/sodium perborate mixture; 200 |LIL sodium linoleate; 
200 f iL luminol. The content was mixed thoroughly on a vortex mixer and 
advanced quickly to position number 12 in the turret by pressing the "Rapid Load" 
button. Then "Next Sample" button was pressed to move the sample from position 
number 12 into the measuring chamber. The "Sample IN" light came on and the pen 
in the chart recorder moved quickly approximately 3/4 of the way across the paper, 
maximizing slowly and started to move down after about 2 to 3 minutes. Best 
results were obtained when the luminescence plateau was reached before addition 
o f Trolox standard or plasma. The luminescence would generally stabilize after 3 
minutes. Trolox standard (15(iL 0.2 mmol/L) was then pipetted by Hamilton 
syringe with a Teflon plastic tube extension (the connection was kept air-tight and 
the tubing long enough to reach the content of reaction mixture) through a vertical 
hole and septum into the measuring chamber. The "Continuous Mixing" button was 
35 
pressed and injection of the standard made at 3-4 minutes. Once the addition was 
made, the luminescence immediately dropped to the zero-baseline. The point o f 
injection was marked and the content mixed for 30 seconds. The luminescence 
recovered when the antioxidant capacity of the standard was exceeded and the 
point marked when it recovered to 10% of the previous luminescence. Trolox 
standard was measured once again after the luminescence recovered. 30 |LIL o f 
plasma (1:5 dilution with PBS) was then injected at about 9-10 minutes, the 
procedure being the same as described for Trolox addition. 
The quenching time for Trolox and plasma were calculated from the time of 
addition to the point when light emission had recovered to 10% of previous 
luminescence. Total assay time was about 12-15 minutes. 
T\n Calculation of TRAP 
T plasma 1 
TRAP (fimol/L)= x 2 x [Trolox] x Dilution Factor x 
T Trolox Volume of Plasma 
T plasma 1 
TRAP (|imol/L)= x2x0 .003 (^imol)x5 x 
T Trolox 30|JL 
T plasma 
= X 1000 
T Trolox 
[Trolox]= 0.2mmol/L x IS^iL =0.003^mol 
Dilution Factor = 5 
Volume of Plasma = 30nL 
T plasma - Quenching time produced by plasma 
T Trolox - Quenching time produced by Trolox 
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3.2.2 Evaluation of the Chemiluminescence Method 
In the following series of evaluation tests, the blood used was collected by 
venipuncture into a lithium heparinized tube, mixed thoroughly and immediately 
centrifuged at 2000 x g for 10 mins. The supernatant plasma was then separated. 
I ) Linearity 
A series of Trolox standards giving rise to TRAP values ranging from 100 
fxmol/L to 10,000 |imol/L were prepared and analysed in duplicate to measure the 
quenching time. The quenching time of the standard was plotted against the TRAP 
value (|Limol/L). The straight portion of the resulting curve represents the analytical 
range of the assay. 
ID Recovery 
Recovery experiment is one of the few ways to assess accuracy of the assay 
in the absence of a reference method and reference materials. I t tests the ability of 
the assay to accurately measure the desired analyte in the presence of all the other 
components in the sample matrix. Two patient's samples were included in this 
study. The experimental protocol is shown in Table 1. 
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Table 1: Recovery ExDerimental Protocol 
. Trap Trap Trap Recovei^ 
Sample Preparation Measured Added Recovered 
1. 540 |iL patient serum + 60nL water A 
2. 540 ixL patient serum + 60^L 0.5 B 100 B-A (B-A)/100x100% 
mmol/L Trolox 
3.540 nL patient serum + 60nL .1.0 C 200 C-A (C-A)/200xl00% 
mmol/L Trolox 
4.540 nL patient serum + 60^L 1.5 D 300 D-A (D-A)/300xl00% 
mmol/L Trolox 
5.540 ^iL patient serum + 60|iL 2.0 E 400 E-A (E-A)/400xl00% 
mmol/L Trolox 
6.540 ^iL patient semm + 60nL 2.5 F 500 F-A (F-A)/500xl00% 
mmol/L Trolox 
7.540 \3L patient serum + 60^L 3.0 G 600 G-A (G-A)/600xl00% 
mmol/L Trolox 
Formula for Calculation: 
VolofStd 
Concentration o f Tro lox added = Std Concentration x-
Vol of Std + Vol of Plasma 
1 . ' 
=Std Concentration x 
10 ‘ 
T R A P added (^imol/L) = 2 x concentration o f Trolox 
T R A P recovered = TRAP measured (test) - TRAP measured (baseline) 
T R A P recovered 
Recovery x 100% 
TRAP added 
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i n ) Precision 
The precision study consisted of estimation o f within-day and between-day 
precision. These measured the magnitude of random error affecting the 
reproducibility o f the measurement. The approach described by Robb I.W.P. et al 
(31) was adopted. 
a) Within-Day Precision: 
Up to 20 normal subjects' bloods were collected and analysed in duplicate. 
The duplicates were not analysed as adjacent pairs but distributed randomly 
throughout the run within the day. SD, CV and mean were calculated. SD in 
this case is calculated according to the following formula: 
SD =/- d=difference between each pair o f duplicate 
J 2N N=number of pair 
b) Between-Day Precision: 
For the between-day precision, six samples were selected from the "within-
day Precision" experiment to span the normal analytical range o f TRAP. 
Each was separated into small aliquots and stored at -70°C. Aliquots from 
the six samples were thawed each day and analysed in duplicate for 14 days. 
The SD, CV and mean for each level were calculated. 
Interference Experiment 
This was to estimate the constant systematic error due to presence o f 
potential interferants in the sample. As the concentration of interferant varied, the 
size of the error varied. The experiment was similar to the recovery experiment 
except that the material added was the interferant instead of the analyte. Hemolysis 
is a common artefact due to improper sampling technique, while lipemia is 
commonly seen in samples obtained from hyperlipoproteinemic patients, the group 
o f interest in our future study. Thus the effect of hemolysis and lipemia on TRAP 
value were evaluated. 
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a) Effect o f Hemolysis on TRAP value: 
E D T A blood was collected and washed 5 times to get rid o f the plasma. I t 
was then traumatized with a wooden stick and centrifuged to obtain the 
pure supernatant hemoglobin solution. This pure hemoglobin solution was 
diluted wi th distilled water to varying concentrations o f hemoglobin which 
were then added to patient's basal sample to give samples ranging from 
slightly to grossly hemolysed. The experimental protocol is shown in Table 
2. 
Table 2; Experimental Protocol for Evaluating Effect of Hemolysis on TRAP 
Value 
Sample Preparation Hb TRAP Interference 
added (g/L) measured 
1 • 540ML patient plasma+60ML distilled Ni l A 
water 
2. 540ML patient plasma+60|jL 5g/L 0.5 B B - A 
Hb solution 
3.540nL patient plasma+60ML7g/L 0.7 C C-A 
Hb solution 
4. 540|LIL patient plasma+60nL 9g/L 0.9 D D - A 
Hb solution 
5.540| iL patient plasma+60nL 17g/L 1.7 E E - A 
Hb solution 
6. 540^1 patient plasma+60ML 53g/L 5.3 F F - A 
Hb solution 
Formula for Calculation: 
Vol of Hb solution 
Hb added = Hb Concentration x 
Vol of Hb solution + Vol of Plasma 
1 
= H b Concentration x 
10 
Interference = TRAP measured (test) - TRAP measured (baseline) 
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b) Effect ofLipemia on TRAP value: 
A 20% intralipid emulsion with a triglyceride concentration o f 490mmoiyL 
was diluted with distilled water to give varying concentrations o f 
triglyceride. These were then added to aliquots o f a patient's basal plasma 
yielding sample from slightly to grossly lipemic. The experimental protocol 
is shown in Table 3. 
Table 3; Experimental Protocol for Evaluating Effect o fL ipemia on T R A P 
Sample Preparation: 
1. 540|xL patient plasma+60|il distilled water 
2. 540|iL patient plasma+GOpL 21.2mmol/L Triglyceride solution 
3. 540|aL patient plasma+60^L 40.6mmol/L Triglyceride solution 
4. 540ML patient plasma+GOpL 58.5mmol/L Triglyceride solution 
5. 540|JL patient plasma+60^L 74.9mmol/L Triglyceride solution 
6. 540nL patient plasma+60nL 90.2inmol/L Triglyceride solution 
7. 540uL patient plasma+60uL 110.6mmol/L Triglyceride solution 
Sample Sample Triglyceride Total Triglyceride TRAP Interference 
Appearance added (mmol/L) Present (mmol/L) measured 
LBasal clear Nil 0.68 A 
2 slightly lipemic 2.12 2.12+0.68=2.80 B B-A 
3 4.06 4.06+0.68=4.74 C C-A 
4 5.85 5.85+0.68=6.53 D D-A 
5 7.49 7.49+0.68=8.17 E E-A 
6 、寿 9.02 9.02+0.68=9.70 F F-A 
7 grossly lipemic 11.06 11.06+0.68=11.74 G G-A 
Formula for Calculation 
Vol of Trig solution 
Triglyceride added: Trig. Concentration 
Vol of Trig solutionH- Vol of Plasma 
1 
=Tr ig . Concentration x 
10 
Interference = TRAP measured (test) - TRAP measured (baseline) 
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V ) Fffect of Storajge on TRAP 
Samples from 6 healthy individuals were each separated into 14 aliquots. 
One of the aliquots was analysed fresh; another was frozen, then thawed and 
subjected to analysis on the same day of collection. Other aliquots were stored at 
different temperatures (.70°C,-20°C, 4°C). After 1 week, 2 weeks, 4 weeks and 12 
weeks, the aliquots were removed, thawed and TRAP measured. Wilcoxon's signed 
ranks sum test was used to compare the paired data. 
5.2.5 Determination of Analytical，Intraindividual and Interindividual Biological 
Variation of TRAP in A Group of Healthy Chinese: 
T) Subject Selection 
a) Number of Subjects: 22 
b) Sex: 14 male; 8 female 
c) Ethnicity: Chinese 
d) Age: 24-56 
c) Health Status: Healthy with no previous record of major disease 
d) Medication: Al l denied taking any medication 
n ) Sample CoHectioiL Processing and Subsequent Storage 
Subjects were asked to report in each study period after an overnight fast 
(10-12 hours). Al l collections were made between 7:00-9:00a.m. 5mL of blood was 
collected by a 21 gauge needle into a commercial lithium heparinized tube 
(Sarstedt) with minimal stasis after the subject had been seated for at least 5 mins. 
The blood was mixed gently and thoroughly for a few minutes and centrifuged 
immediately at 2000 x g for 10 minutes. The supernatant plasma was then stored at 
-70°C for 3 days before TRAP determination. 
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in、Experimental Protocol for Determination o f the Variation Data 
Blood was collected from the 22 healthy subjects at day 1，Iweek, 2 weeks, 
4 weeks and 12 weeks. Each sample was analysed in duplicate in different runs 
within the same day. An aqueous control solution o f Trolox wi th a known 
concentration was included to serve as a quality assurance o f the analysis during the 
12 weeks. Data obtained were then analysed according to the protocol described by 
Fraser (2) to determine the analytical, intraindividual and interindividual variation. 
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rhapter IV Analytical Results 
4.1 Method Evaluation 
4.1.1 Linearity 
Figure 7 illustrates the typical relationship between the quenching time and 
the various concentrations of TRAP. The line of best fit intercepted the y-axis at -
0.107 minutes and was linear to a TRAP concentration of 10,000 |imol/L. This 
encompassed the range of TRAP likely to be seen in biological samples. 
Figure 7: Lineari ty of TRAP assay 
time = 0.00131180 x trap + -0.107262 
Quenching 
Time (min) 
1 4 丁 口 
12 
1。 
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Table 4 shows that the mean of recovery is 101.1% and the range is 92— 
108%. 
Table 4; Recovery; 
Specimen TRAP added TRAP Recovered %Recovery 
(jimol/L) 
A 200 194 97 
A 200 194 97 
B 200 188 94 
B ^ 94 
Mean: 95.5 
Range: 9 4 9 7 
A 400 432 108 
A 400 387 97 
B 400 406 102 
B 400 92 
Mean: 卯 
Range: 92-108 
A 600 588 98 
A 600 588 98 
B 600 601 100 
_B ^22 ^ 101 
Range 98-101 
A 800 838 105 
A 800 829 104 
B 800 843 105 
B 800 . 106 
Mean: 105 
Range: 104-106 
A 1000 1077 108 
A 1000 1045 104 




Overall Mean: 101.1 
Overall Range: 92—108 
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4丄 3 Within-Day and Between-Day Precision 
Tables 5 and 6 show the within-day and between-day precision respectively. 
The within-day precision was obtained by analyzing samples in duplicate from a 
group of normal subjects. This estimate of within-day precision can thus applies to 
normal concentrations of TRAP. The CV is 2.5% for within-day precision as shown 
in Table 5. For between-day precision as shown in Table 6，the CV was 6.2%, 
4.2%, 3.5%, 4.2%, 4.3%, and 3.5% at 527 ^imol/L, 854 |imol/L, 933 ^mol/L, 1119 
|imol/L, 1249 |imol/L and 1425 ^imol/L respectively. 
Table 5: Within-Dav Precision; 
Subject TRAP Value Subject TRAP Value 
1 912/951 11 1037/1019 
2 1053/1051 12 604/604 
3 1119/1119 13 964/928 
4 1018/1000 14 982/982 
5 1132/1123 15 1241/1283 
6 1464/1481 16 1018/982 
7 923/897 17 964/909 
8 1164/1111 18 1500/1438 
9 931/981 19 881/931 
10 1571/1518 20 1036/1091 
Formula for Calculation 
/ Zd^ SD 
Mean=1073 SD= / =26.5 CV= x 100% 
N=20 / 2N Mean 
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Table 6; Between-Dav Precision; 
Sample TRAP Value N Mean (>mol/U SD (^moVD CV (%) 
1 Low 14 527 32 6.2 
2 14 854 36 4.2 
3 14 933 32 3.5 
4 14 1119 46 4.2 
5 V 14 1249 54 4.3 
6 High 14 1425 50 3.5 
4.1,4 Interference 
a)Results of effect of hemoglobin on TRAP value are shown in Table 7. 
Table 7; Effect of Hemolysis on TRAP Value; 
Sample Hb Appearance TRAP Interference 
added (g/L) of plasma measured (umol/L) 
1 .Basal Ni l clear 1026 
2. 0.5 slightly hemolysed 950 -75 
3 0.7 974 -52 
4. 0.9 857 -169 
5. 1.7 y 737 -289 
6. 5.3 grossly hemolysed 606 -420 
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b) Results of the effect oflipemia are shown in Table 8. 
Table 8; Effect ofL ipemia on TRAP Value 
Sample Triglyceride Total Triglyceride Appearance TRAP Interference 
added(mmol/L) Present(inmol/L) of plasma measured 
1.Basal Ni l 0.68 clear 769 
2. 2.12 2.12+0.68=2.80 slightly lipemic 734 -35 
3. 4.06 4.06+0.68=4.74 722 -47 
4. 5.85 5.85+0.68=6.53 770 -1 
5. 7.49 7.49+0.68=8.17 779 10 
6. 9.02 9.02+0.68=9.70 794 25 
7. 11.06 11.06+0.68=11.74 grossly lipemic 822 53 
4.1.5 Effect of Storage on TRAP 
The result of the test samples stored for different period of time at -70°C, 
-20°C and 4。C are shown in Table 9. Graphical representation of these results is 
presented in Figures 8a, 8b and 8c. Wilcoxon's signed ranks sum test was used to 
test the difference of results obtained from fresh samples and stored samples. 
Results show that the "freeze and thaw" process does not result in any significant 
change on TRAP value, and TRAP values remain stable for up to 2 weeks when 
stored at either -70°C or -20°C. They decrease when the samples were stored at 
these two temperatures for 4 weeks. For those samples which were stored at 4°C, 
TRAP value decreases even after 1 week. Bearing this in mind, the samples for the 
determination of biological variation of TRAP were only stored at -70。C for 3 day 
prior to analysis. 
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Figure 8a; Effect of Storage at -70 ^C on TRAP Value 
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Figure 8c; Effect of Storage at 4 ^C on TRAP Value 
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Table 9; Storage Stability of TRAP 
Day Day 1 1 week 2 weeks 4 weeks 12 weeks 
Subject 
1 Fresh 1258 
•freeze and thaw 1199 
. -70。C 1160 1297 1000 1032 
-20。C 1132 980 947 1001 
4 0 c 1056 1020 842 881 
2 Fresh 960 
freeze and tlunr 1001 
- 7 0 ° C 980 1060 822 876 
. 2 0 ° C 961 1001 772 702 
40Q 800 891 786 684 
3 Fresh 1073 
freeze and thaw 1158 
-70。C 1098 1172 956 940 
. 2 0 ° C 1010 1074 885 836 
4 0 ^ 1040 970 842 759 
4 Fresh 908 
freeze and thaw 892 
- 7 0 ° C 900 912 794 768 
-20°C 878 892 737 742 
40Q 831 881 759 714 
5 Fresh 1283 
freeze and thavr 1250 
-70。C 1220 1263 1103 1077 
. 2 0 ° C 1138 1236 945 967 
4 0 c 1057 1108 900 947 
6 Fresh 1000 
freeze and thaw 1054 
- 7 0 ° C 1018 1100 860 919 
. 2 0 ° C 1005 1038 808 740 
40Q 840 933 826 726 
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4,2 Analytical, Intraindividual and Interindividual Variation of 
TRAP in A Group of Healthy Chinese 
4.2.1 Difference in TRAP value obtainedfrom the 22 subjects over time 
Result of TRAP obtained from the 22 healthy Chinese at day 1，1 week, 2 
weeks, 4 weeks and 12 weeks are shown in Table 10 and Figure 9. The overall 
means of TRAP in this group of subjects at different times (day 1，1 week, 2 weeks, 
4 weeks and 12 weeks) are shown in Table 11. One factor repeated-measures 
ANOVA over the five sets of data shows that there is a change in the mean of 
TRAP over time (F二23.5，P< 0.0001). With the aid of the Scheffe test in the 
Abstat^ computer program, mean were tested for significant differences and are 
shown in Table 11. 
Table 11; Overall Mean and SD of TRAP obtained from the 22 Subjects at 
Different Time together with an illustration of Groups that are Significantly 
Different from One Another by the Scheffe Test 
Time N Mean (nmol/L) Standard Deviation 
Day 1 22 1144 186 
1 Week 22 1003 146 
2 Weeks 22 1001 155 
4 Weeks 22 982 151 
12 Weeks 22 1060 141 
Scheffe Test for Groups with Significant Differences (Abstat-computer program) 
Group One Group Two Mean Difference (|imol/L) P 
Day 1 1 Week 140.091 <0.0001 
Day 1 2 Weeks 142.273 <0.0001 
Day 1 4 Weeks 161.727 <0.0001 
Day 1 12 Weeks 84.6818 0.0016 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.2.2 The Effect of Gender on Trap 
To test whether there is a difference in TRAP value between the sexes, the 
mean and SD of the males and females at each period of time (Table 12) were 
tested by student's t test. The TRAP value was significantly higher in men than 
women. This finding was consistent with study done by Coll and Thumham (1) in 
which TRAP measured by both oxygen consumption and chemiluminescence 
method were higher in men than women. 
Tahle 12: Comnarison of TRAP Value in Men and Women 
Time All Cases (n二22) Men (n=14) Women (n=8) 
Mean (SD) Mean (SD) Mean (SD) E 
Dayl 1144 (186) 1212 (165) 1023 (163) 0.0172 
iweek 1003 (146) 1053 (111) 916 (167) 0.0307 
2 weeks 1001 (155) 1053 (140) 910 (143) 0.0334 
4 weeks 982 (151) 1033 (124) 892 (160) 0.0317 
12 weeks 1060 (141) 1110 (110) 973 (154) 0.0242 
4,2.3 Determination of Analytical, Intraindividual and Interindividual 
Variation of TRAP in A Group of Healthy Chinese 
Using the protocol of Fraser (2) for determination of analytical, 
intraindividual and interindividual variation, firstly, the singlicate data from each 
subject (5 data points over a period of 12 weeks) were used to calculate the SD 
which was composed of analytical imprecision (SD^) and intraindividual variation 
(SDj ) of that individual. 
(SD)2 = (SDA)2 + ( S D / 
Analytical variation (SD^) in this case could be calculated using the formula: 
SD^= /—— where d= difference between the paired result 
/ 2N N= number of pairs 
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With this approach, SD, SD^ and SDj for each subject were determined and 
subsequently mean SD, mean SD^ and SDj among the 22 subjects calculated 
(Table 10). Singlicate data from all subjects over 12 weeks (110 data points) were 
used to calculate the overall SD (SD^y j ) which is comprised o f analytical (SD^), 
intraindividual (SDJ) and interindividual variation (SDQ). 
( S D 肌 ) 2 =(mean SD^)^ + (mean SDj)^ + (SD^)^ 
Knowing the value o f SD^ j y, mean SD^,mean SDj, the interindividual biological 
variation (SD^) can finally be determined. In this study, 8 0 ^ ^ = 1 6 7 . 0 , mean 
SD^=29.6, mean SDJ=83.9, thus SDq=141. The significance o f these components 
o f variation wi l l be discussed in chapter V. 
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Chapter V; Discussion 
5.1 Validation of the Method Performance 
The chemiluminescence method for measuring TRAP in plasma exhibits a 
wide range of linear response (linear to 10,000 |imol/L). The recovery of the 
method is good with an average of 101.1%. The within-day and between-day 
precision are acceptable. The CV for within-day precision is 2.5%. For the 
between-day precision, it is below 7% even for the lower concentration o f TRAP 
(527 lamol/L). 
Only 50ML o f sample is needed and the assay takes only 12-15 minutes to 
measure one sample. I t is less time consuming than the oxygen consumption 
method for the determination of TRAP (25,26). These evaluation experiments show 
that the chemiluminescence method established has satisfactory performance. 
5.2 Effect of Storage on TRAP 
Concerning the stability of TRAP under different storage conditions, a study 
by Wayner et al (26) has shown that TRAP value was not significantly changed 
after storage at -80°C for more than 2 weeks using the oxygen consumption 
method. Thumham et al (30) and Lindeman et al (29) stored plasma at -70°C and 
analysed it within 4 weeks using the oxygen consumption method. The result of the 
stability experiment carried out using the chemiluminescence method was consistent 
with what had been claimed by these previous studies. The TRAP value was not 
measurably different after storage at -70°C or -20°C for up to 2 weeks. I t ‘ 
decreased significantly when measured at 4 weeks after storage at these 2 
temperatures. 4°C should not be used to store the sample as TRAP decreases when 
stored at this temperature, even for 1 week. The recommended storage condition is 
thus to keep the sample at -70。C and to analyse it within 2 weeks. In our 
subsequent study of biological variation of TRAP, samples were collected and 
stored at -70°C for 3 days prior to analysis. 
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5,3 Interference of Hemolysis and Lipemia on TRAP assay 
5.3. J Effect of Hemolysis on TRAP 
In this assay, ABAP decomposes at 37°C to give rise to free carbon-
centered radicals at a constant rate (Ri) (32). 
Ri = 1.36 X 10-6 X [ABAP] mol/L/sec 
The length of the induction period (T pi站啦）used for the quantitation of peroxyl 
radical scavenging antioxidants in plasma is related to the Ri by the following 
equation (32): 
n= the stoichiometric number of peroxyl radicals 
T plasma = n [IH] / Ri trapped by each antioxidant 
[IH]= the concentration of antioxidant 
This equation shows that Ri is inversely proportional to T piasma and wil l affect the 
magnitude of TRAP. This concept is useful in explaining the effect of hemolysis on 
TRAP. 
TRAP decreases with increase in concentration of hemoglobin (Table 7). 
One possible reason may be due to the presence of heme in the hemoglobin 
molecule. Heme consists of a tetrapyrrole ring, protoporphyrin IXa, linked to an 
iron I I ion (Fe ). Fe ion released due to heme degradation can take part in 
electron transfer with molecular oxygen (12). 
Fe2+ + O2 ——> [Fe2+-02 <——> Fe^.-CY] > Fe^"^ + O^" 
perferryl group 
Pure lipid peroxides in the reaction mixture are fairly stable at physiological 
temperature but in the presence of transition metals, especially iron, their 
decomposition is greatly accelerated, resulting in the production of alkoxyl (LO.) 
and peroxyl (LOO*) radicals (12). 
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L O O H + FE2+ > + O H " + LO* 
alkoxyl radical 
L O O H + > FE2+ + + L O O . 
peroxyl radical 
In the hemolysed sample, not only the azo-initiator (ABAP) is generating 
peroxyl radicals, hemoglobin is another source of peroxyl radicals due to its action 
on lipid peroxides. The more hemolysed the sample, the more heme protein and the 
more peroxyl radicals generated. In other words, the rate of peroxyl radicals 
production (Ri) is no longer constant, it increases with an increase in hemoglobin 
concentration. An increase in Ri in the above equation wil l result in a decrease in 
the induction period produced by the antioxidants and a lower TRAP value. 
Another point also worth mentioning is that heme iron is claimed to be capable of 
oxidizing tocopherols (Vit E) resulting in decreased availability of Vitamin E for 
trapping peroxyl radicals (33). This might also contribute to the decreasing TRAP 
with increasing hemolysis. 
Slight hemolysis due to hemoglobin up to 0.7g/L wil l not affect TRAP 
significantly，however, moderately to grossly hemolysed samples should be avoided 
since there is a dramatic drop in TRAP in these samples (Table 7). 
5.3.2 Effect ofLipemia on TRAP 
Intralipid emulsion was used in this experiment for evaluating the effect of 
lipemia on the TRAP assay. I t might not be a perfect model in mimicking 
physiological lipid but its use can be justified because it is a lipid emulsion that has 
been specifically designed as a source of high-calorie nutrition and essential fatty 
acids for intravenous administration, and is metabolised in a similar fashion to 
chylomicrons. 
As the concentration of triglyceride increases from 2.12inmol/L to 
11.06mmol/L with addition of intralipid, there is an initial decrease followed by a 
gradual increase in TRAP (Table 8). With such a pattern, it seems that intralipid 
emulsion is exerting 2 simultaneous effects in the sample: i) it might be mopping up 
antioxidants in the sample leading to a decrease in TRAP ii) with its major 
ingredient being soybean oil, it provides extra vitamin E to the sample resulting in 
an apparent rise in TRAP. The decrease or increase in TRAP might depends on the 
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balance between these two factors. Thus the initial drop in TRAP observed with 
slightly lipemic samples might illustrate the process of mopping up antioxidants 
outweighing the provision of vitamin E by the intralipid. On the other hand, with 
fiirther increase in triglyceride concentration, the provision of vitamin E by the 
intralipid might outbalance the mopping up of antioxidants resulting in an increase 
in TRAP. 
The magnitude of the decrease and increase in TRAP seen in the samples 
ranging from slightly lipemic to grossly lipemic (Table 8) is indeed quite small 
compared to the value (249|Limol/L) derived in section 5.5 to judge i f a significant 
difference between the two serial results from a single patient has occurred. Thus it 
is concluded that lipemic samples with a triglyceride level of up to 1 Immol/L could 
be used in the TRAP assay without severely affecting the interpretation of the 
results. 
Use of intralipid in this case is not a perfect model for evaluating the effect 
of lipemia on TRAP since it might contain substances that are not normally present 
in lipemic samples or it might be acting differently when compared to a lipemic 
sample. A better alternative for analysing the effect of lipemia might be to analyse 
lipemic samples before and after ultracentrifugation and then compare the 
difference in the results. 
5,4 Possible Sources of Variation in TRAP Over Time 
In this study, serial samples were collected from a group of healthy Chinese 
over a period of 12 weeks. I t was anticipated that there would be variation in the 
TRAP value obtained at different times in an individual. The components f 
contributing to variation could include (43,45): 
I ) Preanalytical Variation: possible sources of this variation include a) prior 
exercise; b) previous diet; c) drug intake; d) posture; e) inconsistency in 
sampling technique; f) processing of the specimen; g) difference in time of 
transportation of specimens to the laboratory; h) storage time prior to 
measurement, etc. 
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I I ) Analytical Variation: variation due to random error inherent in the 
method, both within-run and between-run. 
HI、Biological (Intraindividual) Variation: variation around the homeostatic 
setting point in an individual which might be due to a) diet; b) stress; c) 
circadian variation; d) seasonal change; e) exercise; f) posture; g) drug 
intake, etc. 
In this project, preanalytical variation is minimized by i) making sure that 
no drugs were taken by the subjects during the period of investigation; i i) collection 
o f fasting blood samples at the same time of the day during each period (for 
excluding variations due to recent dietary intake and diurnal fluctuation); iii) 
standardized blood collection procedures with minimal stasis to prevent relative 
hemoconcentration; iv) processing and storage of samples prior to analysis were 
kept consistent. However, these subjects' lifestyle, physical activity, stress level 
and/or dietary habit were not known, and were possibly contributing to 
intraindividual variation over time. 
As the diet is a major source of antioxidants in the plasma, dietary variation 
might be expected to contribute appreciably to intraindividual variation of TRAP. 
There might also be other factors that account for preanalytical and intraindividual 
variation o f TRAP : 
I ) Ascorbic Acid: 
Ascorbic acid levels in blood mainly reflect current dietary intake rather than 
readily available tissue stores. I t varies with dietary intake, an intake o f 
/ 
lOOmg/day wil l increase the serum level to a maximum of about 12mg/L 
whereas with an intake less than lOmg/day, the serum ascorbic acid wi l l 
drop to l -2mg/L (34). Moreover, ascorbic acid in blood has been shown to 
be significantly reduced in case of a) stress; b) anxiety; c) grief; d) moderate 
to heavy alcohol consumption; e) common cold and f) heavy cigarette 
smoking (every cigarette is said to destroy 25mg of vitamin C) (35). 
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II、Protein Sulfhvdrvl group 
Emotional stresses such as fear, anxiety or anger wi l l increase secretion o f 
epinephrine, which in turn causes a series of changes resulting in loss of 
nitrogen. The stress of cold also increases nitrogen excretion. Since protein 
is a constant source o f nitrogen, its level and hence the sulfhydryl content is 
likely to be affected by these situations (34). Prolonged application o f a 
tourniquet during blood collection wil l increase filtration pressure across the 
capillary walls, and this wil l cause fluid and components with a molecular 
weight o f <5000 to pass through wall resulting in a relative 
hemoconcentration. A three minutes stasis is likely to increase concentration 
o f protein or protein-bound constituents by 15% (36). This factor was 
minimized in our experiments as standardized blood collection procedures 
were employed with minimal stasis. 
i m Uric Acid 
Uric acid concentration in blood is affected by dietary purine content and 
general level of activity (37). A previous study shown that uric acid as an 
end product of catabolism appears to be one of those analytes that exhibit 
the largest biological variation, both intraindividually (9-12%) and 
interindividuaUy (15-20%) (38). 
Vitamin E 
Lipoproteins are the major carriers of vitamin E in the circulation (39). 
After selective precipitation, it has been found in men that L D L and V L D L 
carry 56.1% of the circulating a-tocopherol compared with 43.9% in HDL, 
while in women, 45.4% of a-tocopherol is present in L D L and V L D L 
compared with 54.6% in HDL (40). Major behavioural factors affecting 
lipid, lipoprotein and apolipoprotein concentrations such as diet, obesity, 
cigarette smoking, alcohol, caffeine intake, exercise and stress wi l l indirectly 
affect the concentration of a-tocopherol from time to time (41). 
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The overall mean of TRAP at each point in time would not be expected to 
change unless there were seasonal effects or other effects intermittently affecting 
the whole group. With the powerful statistical test one factor repeated-measures 
ANOVA, the large group of subjects and measurements, one is able to detect a 
change in the mean of TRAP over the period of 12 weeks (F=23.5, p<0.0001). The 
SchefFe test in the Abstat^ program shows that the mean at day 1 is significantly 
higher than that at 1 week, 2 weeks, 4 weeks and 12 weeks, while the mean at 4 
weeks is significantly lower when compared to mean at 12 weeks (Table 11). 
Variation in the mean result for a population studied over a period o f time may 
simply be due to chance because of within-run analytical error. However, it is 
known (37) that variations in the mean for a population over time are also due to 
additional error between-run. I f a method showed small systematic variation 
between-run, then a powerful statistical technique such as one factor repeated-
measures A N O V A might be able to detect these variations. I t is possible that the 
significant effect of time on the TRAP value studied in this population is simply due 
to analytical effects，but we cannot rule out the possibility of small seasonal effects 
or other influences on the whole group, e.g. wide spread changes in diet due to 
availability of particular food items. The major analytical effect that could account 
for the change in the mean of TRAP over time is likely to be due to slight between-
run variation of quenching time given by the standard Trolox. This is unlikely to be 
due to variation in the Trolox standard itself since it was weighed out carefully, 
made up to volume, dispensed into small aliquots and stored at -70°C; prior to 
analysis, the aliquots were thawed and mixed thoroughly to ensure homogeneity. 
The variation probably is due to day to day differences in instrumental conditions 
and operation. An aqueous control solution of Trolox with a known concentration 
was analysed along with the samples to serve as a quality assurance of the assay 
during the 12 weeks. The control values were all within the pre-defined QC limit as 
established. 
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5.5 Usefulness of the Variation Data of TRAP obtained from a Group of 
Healthy Chinese 
Biological variation data has proved to be useful in several respects in 
clinical biochemistry. The value of these data is supported by their marked 
constancy over time, between different sized subject groups, and between subject 
groups from a variety of countries (42). A hypothesis has been proposed by Fraser 
(43) after careful comparison of the variation data of a series o f analytes obtained 
from healthy subjects and patients with different disease: "In the short term at least, 
in all diseases that cause abnormal or normal clinical chemistry results, but in which 
a new homeostatic steady state is achieved, the biological intraindividual variation 
o f plasma analytes would be similar to those in healthy peer group." This thus 
suggests that biological variation data are valid and can be widely used in the 
interpretation o f routine clinical biochemistry results even when such data are 
derived from healthy individuals (43). "Healthy" individuals were recruited for the 
study of biological variation of TRAP. The criterion of "healthy" was their self-
confession of not having any major disease. 
A knowledge of biological variation data can be useful in several aspects of 
clinical biochemistry: 
i) They can be used for setting analytical goals for imprecision of the 
test. I t is suggested that the analytical variation (imprecision) of the 
assay should be equal to or less than one half of the intraindividual 
biological variation (2). 
SD < 1/ SD 
analytical 一 2 intraindividual • 
With this approach, low analytical imprecision wil l be required i f the 
biological variation around the homeostatic setting point is small. 
This wil l ensure that analytical imprecision wil l not widen the 
reference interval and prevent real change in individual patients from 
being detected. It has been suggested that analytical goals for 
imprecision based upon biological variation are the most stringent 
among those currently used (42). The analytical goal for imprecision 
of the chemiluminescence method for measuring TRAP is fulfilled 
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since SD^ with a value of 29.6 is less than one half o f the SDj 
(83.9+2=42). 
i i) Conventionally, population-based reference values are used to aid 
diagnosis. However, one has to bear in mind that these can only be 
applicable to those analytes with interindividual variation smaller 
than intraindividual variation. In the case o f those analytes with 
interindividual variation greater than intraindividual variation, 
individuals might have values that are highly unusual for themselves 
but still lie within the population-based reference limits. Use o f 
reference intervals in this case wi l l be misleading. Formally, an 
"Index o f Individuality" can be calculated using the biological 
variation data according to Harris (44). 
/ (SDintraindividual) 
Index of Individuality = 丨 
w (SDinterindividual) 
When this index is high, particularly more than 1.4，conventional 
reference intervals are of most use. When this index is low, 
particularly when less than 0.6，conventional reference values are of 
limited utility in interpretation of results. In the case of TRAP, the 
Index o f Individuality is 0.6 which indicates that a population-based 
reference interval is insensitive in detecting change in an individual 
(Figure 10). Comparison of TRAP values with those previously 
obtained in the same individual would be of greater value. 
/ 
i i i) To be 95% certain that two test results from a single patient are 
significantly different, they should differ by 2.8 SD (2). SD in this 
case is not only due to analytical variation (imprecision) o f the assay 
but also biological intraindividual variation. 2.8xSD for TRAP 
equals 249. This means that when a TRAP value of an individual 
differs from a previous measurement by 249 |amol/L, one can be 
95% confident that the difference is significant. With the availability 
o f this information, one would be able to judge, for example, i f there 
were significant change in TRAP values before and after imposition 
oflipid-lowering dietary therapy in hyperlipoproteinemic patients. 
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As an extension o f this project, it is anticipated that with the availability o f 
the TRAP assay and knowledge of the biological variation of TRAP, it wi l l be o f 
application in assessing whether lipid-lowering dietary therapy commonly employed 
in treatment o f hyperlipoproteinemia imposes any significant change in TRAP 
value. Wi th increasing awareness of the role played by oxidized L D L in the 
aetiology o f atherosclerosis, it is likely that both lipid-lowering dietary therapy 
(which acts to decrease plasma cholesterol and specifically LDL-cholesterol levels) 
and antioxidants (which act to protect L D L from oxidative damage) wi l l decrease 
the risk o f atherogenesis in hyperlipoproteinemic patients. By measuring TRAP in 
hyperlipoproteinemic patients before and after lipid-lowering dietary therapy wi l l 
enable us to determine i f the lipid-lowering diet exerts any effect on the secondary 
chain-breaking antioxidant capacity in plasma. I f so, this wi l l further validate its use 
against atherosclerosis in hyperlipoproteinemia. However, i f no obvious or a 
negative effect is observed, antioxidant therapy might be considered as another 
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